Impact of brain tumour treatment on quality of life

被引:111
作者
Heimans, JJ
Taphoorn, MJB
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Neurol G03228, NL-3508 GA Utrecht, Netherlands
关键词
primary brain tumour; glioma; quality of life; cognitive function;
D O I
10.1007/s00415-002-0839-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Measurement of Health Related Quality of Life (HRQL) in brain tumour patients is important because brain tumours and brain tumour treatment usually affect physical, cognitive as well as emotional functioning. Measurement of HRQL is important for the understanding of disease burden and for the impact of specific tumour treatment. Quality of Life is a multidimensional concept consisting of physical, psychological and social phenomena. A large number of Quality of Life instruments have been developed. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the MOS Short-Form Health Survey are two frequently used general HRQL instruments. A specific brain tumour scale is the Brain Cancer Module, which is designed to be used in combination with general questionnaires. HRQL measurement and neuropsychological examination were used to investigate the impact of radiotherapy and surgery in low-grade glioma patients and the influence of tumour volume, tumour localization, performance status and age in both low-grade and high-grade glioma patients.
引用
收藏
页码:955 / 960
页数:6
相关论文
共 29 条
[1]   Mood disorders in patients after treatment for primary intracranial tumours [J].
Anderson, SI ;
Taylor, R ;
Whittle, IR .
BRITISH JOURNAL OF NEUROSURGERY, 1999, 13 (05) :480-485
[2]   Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment [J].
Bampoe, J ;
Laperriere, N ;
Pintilie, M ;
Glen, J ;
Micallef, J ;
Bernstein, M .
JOURNAL OF NEUROSURGERY, 2000, 93 (06) :917-926
[3]   RECURSIVE PARTITIONING ANALYSIS OF PROGNOSTIC FACTORS IN 3 RADIATION-THERAPY ONCOLOGY GROUP MALIGNANT GLIOMA TRIALS [J].
CURRAN, WJ ;
SCOTT, CB ;
HORTON, J ;
NELSON, JS ;
WEINSTEIN, AS ;
FISCHBACH, AJ ;
CHANG, CH ;
ROTMAN, M ;
ASBELL, SO ;
KRISCH, RE ;
NELSON, DF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (09) :704-710
[4]  
DELMAR SB, 2000, J CLIN ONCOL, V18, P3295
[5]  
Gilbert M, 2000, SEMIN ONCOL, V27, pS20
[6]   A CRITICAL-APPRAISAL OF THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS [J].
GILL, TM ;
FEINSTEIN, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (08) :619-626
[7]   Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour [J].
Giovagnoli, AR .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (03) :358-363
[8]   RECORDING NEUROLOGICAL IMPAIRMENT IN CLINICAL-TRIALS OF GLIOMA [J].
GRANT, R ;
SLATTERY, J ;
GREGOR, A ;
WHITTLE, IR .
JOURNAL OF NEURO-ONCOLOGY, 1994, 19 (01) :37-49
[9]   CONFIDING IN CRISIS - GENDER DIFFERENCES IN PATTERN OF CONFIDING AMONG CANCER-PATIENTS [J].
HARRISON, J ;
MAGUIRE, P ;
PITCEATHLY, C .
SOCIAL SCIENCE & MEDICINE, 1995, 41 (09) :1255-1260
[10]   TEST-RETEST STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CORE QUALITY-OF-LIFE QUESTIONNAIRE [J].
HJERMSTAD, MJ ;
FOSSA, SD ;
BJORDAL, K ;
KAASA, S .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1249-1254